Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.87
-0.45 (-2.60%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $433.83 million as of April 28, 2025. Its market cap has decreased by -15.04% in one year.
Market Cap
433.83M
Enterprise Value
175.77M
1-Year Change
-15.04%
Ranking
Category
Stock Price
$16.87
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $433.83M, an increase of 95.71%. That is a compound annual growth rate of 55.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 433.83M | -16.58% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |